Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;34(9):1677-1679.
doi: 10.1007/s11606-019-05033-3.

Changes in Price for Generic Drugs in the USA, 2008-2016

Chintan V Dave  1 , Gregory Brill  2 , Aaron S Kesselheim  2
Affiliations

Changes in Price for Generic Drugs in the USA, 2008-2016

Chintan V Dave et al. J Gen Intern Med. 2019 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they do not have a conflict of interest.

Figures

Figure 1
Figure 1
Mean and median percentage change in generic drug prices, 2008–2016 for the overall cohort of generic drugs, and within terciles of prescribing frequency. Drug prices were estimated for 1099 generic drugs for the 14 study periods (not adjusted for inflation). Prices estimated in the first half of 2008 were used as reference. Baseline prescribing frequency was estimated by dividing the number of study-drug dispensings by the total number of dispensings in the baseline period; using terciles, study drugs were grouped into three prescription frequency groups, with the highest tercile corresponding to the most commonly prescribed drugs. The red line represents the mean change in prices and the blue median. The lowest-, middle-, and highest-prescribing frequency groups are represented by (L), (M), and (H) respectively, while the overall cohort is represented with (O).
See this image and copyright information in PMC

References

    1. Dave CV, Hartzema A, Kesselheim AS. Prices of generic drugs associated with numbers of manufacturers. N Engl J Med. 2017;377(26):2597–2598. doi: 10.1056/NEJMc1711899. - DOI - PubMed
    1. Dave Chintan V., Kesselheim Aaron S., Fox Erin R., Qiu Peihua, Hartzema Abraham. High Generic Drug Prices and Market Competition. Annals of Internal Medicine. 2017;167(3):145. doi: 10.7326/M16-1432. - DOI - PubMed
    1. Dave Chintan V., Pawar Ajinkya, Fox Erin R., Brill Gregory, Kesselheim Aaron S. Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study. Value in Health. 2018;21(11):1286–1290. doi: 10.1016/j.jval.2018.04.1826. - DOI - PubMed
    1. Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA. 2016;316(8):858–871. doi: 10.1001/jama.2016.11237. - DOI - PubMed
    1. Dabora MC, Turaga N, Schulman KA. Financing and distribution of pharmaceuticals in the United States. JAMA. 2017;318(1):21–22. doi: 10.1001/jama.2017.5607. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources